M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine, recommends shifts in policies that could expand federally qualified health centers.
M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine, recommends shifts in policies that could expand federally qualified health centers.
Transcript
What policies do you think could expand the safety net role that federally qualified health centers play?
Thankfully, there has been bipartisan support and increasing funding and different programs and different tests to see how the health center program can grow and expand and better meet this need that persists, unfortunately. So, the community health center fund was the big one that came out of the Affordable Care Act and before that there was additional expansion and funding, they did capital health funding for health centers, then even before that before the recession there was expansion money for new access sites so I would say, continuing that additional funding which I believe congress just did support the continuation of the health center funding, which is fabulous.
Also thinking about how Medicaid expansion in states that didn’t expand it might affect some of these health centers because they do get reimbursed if they have an enhanced reimbursement for Medicaid. So, that does help them if their payer mix is a little more balanced. It helps them serve more uninsured patient population if they have more people with insurance to balance that out but they make it either way.
Then, there’s also been interesting funding out of CMS that providing demonstration projects to health centers to become patient centered medical homes, for example. There’s the advanced care primary practice demonstration. And some other quality improvement tests that there’s been funding for because health centers have been very under resourced and usually really understaffed. I worked in one for a very long time and people they are very creative and able to do a lot with very little money. But I think thinking about improving the quality and services they provide, providing access points where there is need and giving the opportunity to grow and meet, we know that demand is growing, see how they can meet that need best and that takes a little bit of funding and resources and nuance. Any support [Health Resources and Services Administration] could give or CMS can give through different reimbursement strategies and testing that out would be my recommendation.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More